Stay updated on RP2 Monotherapy and RP2 with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the RP2 Monotherapy and RP2 with Nivolumab Clinical Trial page.

Latest updates to the RP2 Monotherapy and RP2 with Nivolumab Clinical Trial page
- Check6 days agoChange DetectedThe page’s displayed revision/version string was updated from v3.5.2 to v3.5.3, reflecting a site/UI software update rather than a change to the study record details.SummaryDifference0.1%

- Check13 days agoChange DetectedSponsor name updated to 'Replimune, Inc.' and a new revision 'Revision: v3.5.2' was added; the previous entries 'Replimune Inc.' and 'Revision: v3.5.0' were removed.SummaryDifference0.3%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedA new revision v3.5.0 is added to the Study Record Versions, and the previous revision v3.4.3 is removed.SummaryDifference0.1%

- Check49 days agoChange DetectedThe study record history now includes a new revision entry: v3.4.3. The previous revision v3.4.2 has been removed.SummaryDifference0.1%

- Check56 days agoChange DetectedRecruitment status updated from Recruiting to Active, not recruiting. Added sections include Contacts/Locations, Oversight, and Study Status.SummaryDifference0.7%

- Check78 days agoChange DetectedA new Revision: v3.4.2 entry was added, and the old funding-lapse notice and Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to RP2 Monotherapy and RP2 with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RP2 Monotherapy and RP2 with Nivolumab Clinical Trial page.